Shanghai Fujun Gene Biotechnology Co., Ltd. is a holding subsidiary of Xilong Science (stock code: 002584). Established jointly with Fulgent Genetics, a leading enterprise in precision medicine and genetic diagnosis in the United States. It has the world's most advanced medical laboratory equipment and Qualcomm quantitative gene analysis platform. Based on the verified human genome data, CLIA and CAP laboratories of the United States were established in China by introducing Fulgent's leading artificial intelligence, computer science and gene detection and analysis technologies, and combined with the clinical cooperation experience with hundreds of internationally renowned hospitals and large-scale people, they provided gene sequencing, gene information big data analysis and gene consultation services in an all-round way.
Legal Representative: Zhao Ye.
Established: 2017-11-22.
Registered capital:100000 yuan.
Industrial and commercial registration number: 310120003914566.
Type of enterprise: other limited liability companies
Company address: Room 452 1 Building 1466, Jinxing Village, Jinhui Town, Fengxian District, Shanghai.